Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
06/02/2009 | CA2480564C Novel root-knot nematode-resistance gene and application thereof |
06/02/2009 | CA2395364C Model animal with onset of collagen-induced arthritis |
06/02/2009 | CA2193810C Compartmentalized tissue culture flask |
06/02/2009 | CA2068863C Particle-mediated transformation of animal tissue cells |
05/28/2009 | WO2009067601A1 Cryopreservation of cells using cross-linked bioactive hydrogel matrix particles |
05/28/2009 | WO2009067563A1 Generation of pluripotent cells from fibroblasts |
05/28/2009 | WO2009066922A2 Method of differentiating islet-neighboring cells into insulin- secreting cells |
05/28/2009 | WO2009066817A1 Method for inducing differentiation of human mesenchymal stem cells into motor neurons |
05/28/2009 | WO2009066761A1 Process for production of non-natural protein having ester bond therein |
05/28/2009 | WO2009066702A1 Anti-hiv monoclonal antibody |
05/28/2009 | WO2009066655A1 Human antibody capable of inducing apoptosis |
05/28/2009 | WO2009066258A1 Methods for identifying, purifying and enriching immature or stem cancer-initiating cells from tumors and use thereof |
05/28/2009 | WO2009066256A1 Rice non-endosperm tissue expression promoter (ostsp i) and the use thereof |
05/28/2009 | WO2009065982A1 Peptides that can bind to scurfin and uses thereof |
05/28/2009 | WO2009065301A1 Rice's non-endosperm tissue-specific expression promoter, ostsp i, and uses thereof |
05/28/2009 | WO2009046334A4 Mutated acetohydroxyacid synthase genes in brassica |
05/28/2009 | WO2009045575A3 Unmarked recombinant intracellular pathogen immunogenic compositions expressing high levels of recombinant proteins |
05/28/2009 | WO2009034436A3 'hematopoietic cells that express tmcc-1' |
05/28/2009 | WO2009029591A3 Monoclonal antibody which binds met in formalin-fixed and paraffin-embedded tissues and related methods |
05/28/2009 | WO2008066330A8 Use of a composition contaning human umbilical cord blood-derived mesenchymal stem cell for inducing differentiation and proliferation of neural precursor cells or neural stem cells to neural cells |
05/28/2009 | WO2007067596A3 Methods and compositions for needleless delivery of antibodies |
05/28/2009 | US20090138990 Methods and compositions to increase plant resistance to stress |
05/28/2009 | US20090138987 expression of the nucleic acid sequence in the plant results in increased tolerance to environmental stress (drought, cold, oxidation) |
05/28/2009 | US20090138986 Regulatory Elements Associated with CBF Transcription Factors of Maize |
05/28/2009 | US20090138984 Genes involved in tolerance to environmental stress |
05/28/2009 | US20090138983 AtBG1 {Arabidopsis thaliana beta -glucosidase 1); plant having resistance to various environmental stresses by increasing the level of abscisic acid (ABA), stresses including low temperature, salt damage and dehydration owing to the increased level of ABA |
05/28/2009 | US20090138981 Transcription factors incorporated into expression vectors, and ectopically expressed in plants; transgenic plants with disease resistance, and various other traits such as tolerance to heat, cold, drought, or low nutrient conditions, altered oil content, leaf phenotypes |
05/28/2009 | US20090138978 Use of bridge-1 and activators and inhibitors thereof in the treatment of insulin deficiency and diabetes |
05/28/2009 | US20090138977 Pancreatic cancer targets and uses thereof |
05/28/2009 | US20090138074 Decellularized extracellular matrix of conditioned body tissues and uses thereof |
05/28/2009 | US20090137782 Recognize aberrant glycosylated form of the EGFR; evident upon aberrant post-translational modification; cancer |
05/28/2009 | US20090137680 Novel non-selective cation channel in neuronal cells and method for treating brain swelling |
05/28/2009 | US20090137671 Methods of treating metabolic disorders |
05/28/2009 | US20090137659 Compounds that modulate intracellular calcium |
05/28/2009 | US20090137654 Methods of modulating binding of son of sevenless to phosphatidic acid and identifying compounds that modulate such binding |
05/28/2009 | US20090137644 Rhodanine compositions for use as antiviral agents |
05/28/2009 | US20090137590 N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders |
05/28/2009 | US20090137588 Heteroaryl compounds and uses thereof |
05/28/2009 | US20090137575 Fused Tetracyclic mGluR1 Antagonists as Therapeutic Agents |
05/28/2009 | US20090137535 Substituted oxazolidinone derivatives |
05/28/2009 | US20090137503 Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer |
05/28/2009 | US20090137502 Riproximin, a Novel Type II Ribosome-Inactivating Protein and Uses Thereof |
05/28/2009 | US20090137494 Tumor-activated prodrug compounds and treatment |
05/28/2009 | US20090137484 Neuronal Network-Interacting Peptide |
05/28/2009 | US20090137481 Antimicrobial polypeptides |
05/28/2009 | US20090137476 Apo-2 ligand variants and uses thereof |
05/28/2009 | US20090137471 Ngf variants |
05/28/2009 | US20090137457 Pyrimidinedione derivatives |
05/28/2009 | US20090137394 Zea mays nfb2 promoter |
05/28/2009 | US20090137051 Monoclonal Antibodies Directed Against The Microtubule-Associated Protein Tau |
05/28/2009 | US20090137046 Splicing-Mediated Regulation Of Gene Expression |
05/28/2009 | US20090137044 Schistose microfibrillated article for cell growth |
05/28/2009 | US20090137043 Methods for modification of polymers, fibers and textile media |
05/28/2009 | US20090137042 Processes and systems for hydrating and seeding medical implants with biological components |
05/28/2009 | US20090137041 3-hydroxyisothiazole-4-carboxamidine derivatives as chk2 inhibitors |
05/28/2009 | US20090137040 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |
05/28/2009 | US20090137038 Methods of proliferating stem cells |
05/28/2009 | US20090137037 Nucleic acids coding for humanized antibodies for binding sphingosine-1-phosphate |
05/28/2009 | US20090137036 Tweak receptor |
05/28/2009 | US20090137035 Tweak receptor |
05/28/2009 | US20090137034 Methods for perfusion and plating of primary hepatocytes and a medium therefore |
05/28/2009 | US20090137033 Novel fluorescent proteins from aequorea coerulscens and methods for using same |
05/28/2009 | US20090137023 Cytoplasm of Eukaryotic cells for reprogramming of somatic cells, healing, repairing and therapeutic applications |
05/28/2009 | US20090137019 Thermostable luciferases and methods of production |
05/28/2009 | US20090137017 Generation and isolation of antigen-specific t cells |
05/28/2009 | US20090137005 IL-12 for Expression in Mammalian Cell |
05/28/2009 | US20090137003 Methods for recombinant manufacturing of anti-RSV antibodies |
05/28/2009 | US20090137002 Anti ephb4 antibodies and antibody fragments |
05/28/2009 | US20090137001 Process for preparing recombinant human thrombin with culture cell |
05/28/2009 | US20090137000 Dna polymerases and related methods |
05/28/2009 | US20090136999 Compositions and methods for immunotherapy of cancer and infectious diseases |
05/28/2009 | US20090136997 Pro1550 polypeptides and nucleic acids encoding the same |
05/28/2009 | US20090136988 Method and device to fractionate stem cells |
05/28/2009 | US20090136982 Cell separation using microchannel having patterned posts |
05/28/2009 | US20090136975 transient receptor potential (TRP) family of ion channels; recombinant vectors, host cells; high throughput screening, drug screening |
05/28/2009 | US20090136970 Nogo receptor homologues and their use |
05/28/2009 | US20090136964 Novel anti-heparan sulfate antibody, method for detection of heparan sulfate, and kit for detection of heparan sulfate |
05/28/2009 | US20090136959 Novel genes encoding proteins having prognostic, diagnostic preventive, therapeutic, and other uses |
05/28/2009 | US20090136955 Protocols for making hepatocytes from embryonic stem cells |
05/28/2009 | US20090136950 Immunoglobulin display vectors |
05/28/2009 | US20090136940 Phosphoramidite nucleoside analogs |
05/28/2009 | US20090136927 enhancing the specific productivity ratio of antibody expression of a mammalian cell line which expresses an antibody of interest using knock out techniques; inserting expression promoters rather than anti-sense RNA or other expression suppression constructs |
05/28/2009 | US20090136925 Identification of terpenoid-biosynthesis related regulatory protein-regulatory region associations |
05/28/2009 | US20090136914 Identification and use of genes encoding holins and holin-like proteins in plants for the control of microbes and pests |
05/28/2009 | US20090136912 Carrier for cell culture |
05/28/2009 | US20090136580 PREFERENTIAL KILLING OF CANCER CELLS AND ACTIVATED HUMAN T CELLS USING ZnO NANOPARTICLES |
05/28/2009 | US20090136561 Non-peptidyl agents with pHSP20-like activity, and uses thereof |
05/28/2009 | US20090136559 Chondrocyte Differentiation from Human Embryonic Stem Cells and Their Use in Tissue Engineering |
05/28/2009 | US20090136553 Triggerably dissolvable hollow fibers for controlled delivery |
05/28/2009 | US20090136552 Growth factors nsg28, nsg30, and nsg32 |
05/28/2009 | US20090136530 Influenza Hemagglutinin and Neuraminidase Variants |
05/28/2009 | US20090136528 Novel immunogenic epitope for immunotherapy |
05/28/2009 | US20090136525 Immunoglobulins Comprising Predominantly a Glcnacman3Glcnac2 Glycoform |
05/28/2009 | US20090136524 Compositions and methods for diagnosis and treatment of tumors |
05/28/2009 | US20090136523 Anti-cd26 antibodies and methods of use thereof |
05/28/2009 | US20090136516 Cd-20 specific antibodies and methods of employing same |
05/28/2009 | US20090136512 CXCL13 Antagonists and Their Use for the Treatment of Inflammatory Diseases |
05/28/2009 | US20090136510 Inhibition of macrophage-stimulating protein receptor (RON) and methods of treatment thereof |
05/28/2009 | US20090136508 Method of diagnosing colon and gastric cancers |
05/28/2009 | US20090136507 HBM variants that modulate bone mass and lipid levels |